Back to Journals » OncoTargets and Therapy » Volume 13

Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial Program

Total article views   HTML views PDF downloads Totals
4,142 Dovepress* 3,669+ 566 4,235
PubMed Central* 473 143 616
Totals 4,142 709 4,851
*Since 7 December 2020

View citations on PubMed and Google Scholar